Exomnis Biotech

Kanvas Biosciences

This company develops microbiome mapping platforms and live biotherapeutic products for pharmaceutical companies and research institutions focused on treating cancer and inflammatory diseases.

Esphera SynBio

This synthetic biology company develops engineered exosome therapies to deliver therapeutic payloads for cancer and infectious disease treatments within the biopharmaceutical sector.

DualTPharma

This company develops bacteria-based drug delivery systems to transport immunotherapies into solid tumours for cancer patients.

BioMoti

This company develops targeted drug delivery technology for cancer therapeutics, primarily serving the pharmaceutical and biotechnology industries.

Humane Genomics

This company develops synthetic oncolytic viral therapies to treat cancer patients by engineering viruses that selectively infect and destroy malignant cells.

CHAIN Biotech

This biotechnology company develops oral vaccines and microbiome therapeutics using engineered bacteria to treat solid tumour cancers and chronic diseases for pharmaceutical partners.

Exogene

This biotechnology company develops artificial intelligence and screening platforms to discover T-cell receptor-based cell therapies for oncology researchers and pharmaceutical developers.

Bactheravax

This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.